John Muir Medical Center-Walnut Creek

Summary

John Muir Medical Center-Walnut Creek is a medical facility located in Walnut Creek, California. This center is recognized for care of Breast Cancer, Ovarian Cancer, Uterine Cancer, Breast cancer, Fallopian Tube Cancer and other specialties. John Muir Medical Center-Walnut Creek is involved with conducting 70 clinical trials across 134 conditions. There are 4 research doctors associated with this hospital, such as Babak Edraki, MD, Gigi Q. Chen, Tiffany H. Svahn, and Marjaneh Moini.

Top PIs

Clinical Trials running at John Muir Medical Center-Walnut Creek

Lung Cancer

Ovarian Cancer

Colorectal Cancer

Esophageal Carcinoma

Esophageal cancer

Uterine Cancer

Breast Cancer

Stomach Cancer

Bladder Cancer

Cancer

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.

Recruiting

2 awards

Phase 3

12 criteria

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.

Recruiting

2 awards

Phase 3

27 criteria

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria